Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBKR vs GSK✓SelectedUSD · GSKIBKR vs GSK performance historyLatest closeAs of-5.90%11/20
Stock and ETF performance explorer

IBKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,090.9%
GSK return
+115.7%
Excess return
+975.2%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.9%-0.1%-5.8%-5.8%
7D-13.0%-5.3%-7.6%-11.0%
30D-16.6%-3.7%-12.9%-15.5%
3M-20.7%-7.3%-13.4%-18.6%
6M-14.9%-4.2%-10.6%-14.6%
YTD+11.0%+0.9%+10.2%+8.0%
1Y+16.1%+7.3%+8.9%+9.9%
3Y+265.9%+52.7%+213.1%+180.0%
5Y+292.2%+40.1%+252.1%+206.5%
10Y+699.4%+98.7%+600.7%+397.6%
All+1,090.9%+115.7%+975.2%+451.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling